HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
HC Wainwright & Co. : Rigel Pharmaceuticals (RIGL.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $15.00.
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
Rigel Pharmaceuticals Analyst Ratings
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
Holding Steady: A Detailed Analysis of Rigel Pharmaceuticals' Performance and Prospects
Rigel Pharmaceuticals Analyst Ratings
Piper Sandler Assumes Rigel Pharmaceuticals at Neutral, Announces Price Target of $2
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target